32
https://pubmed.ncbi.nlm.nih.gov/38114365
The study found that sentinel lymph node biopsy (SLNB) does not adversely affect the survival of cT3-4c breast cancer patients with 1-2 sentinel lymph node metastases, compared to axillary lymph node dissection.